Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Medium/long-chain fat emulsion injection is a sterile lipid emulsion intended for intravenous administration as a source of calories and essential fatty acids in parenteral nutrition. It typically consists of a mixture of medium-chain triglycerides (MCT) and long-chain triglycerides (LCT, usually derived from soybean oil). MCTs are more rapidly cleared from the circulation and oxidized for energy compared to LCTs, providing a quick energy source and reducing the risk of liver accumulation. LCTs provide essential omega-6 and omega-3 fatty acids necessary for structural integrity of cell membranes and inflammatory modulation. This formulation is used for patients who cannot receive adequate nutrition orally or enterally.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on medium-chain and long-chain triglycerides fat emulsion.